272 related articles for article (PubMed ID: 6630299)
1. In vitro growth inhibition of murine leukemia cells by antibody specific for the major envelope glycoprotein (gp71) of Friend leukemia virus.
Genovesi EV; Collins JJ
J Cell Physiol; 1983 Nov; 117(2):215-29. PubMed ID: 6630299
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility of Friend virus antigen-modulated erythroleukemic cells to lysis by T lymphocytes from mice with dormant Friend virus infections.
Genovesi EV; Marx PA; Wheelock EF
J Immunol; 1979 Mar; 122(3):795-800. PubMed ID: 312825
[TBL] [Abstract][Full Text] [Related]
3. Use of adoptive transfer and Winn assay procedures in the further analysis of antiviral acquired immunity in mice protected against Friend leukemia virus-induced disease by passive serum therapy.
Genovesi EV; Pettey CL; Collins JJ
Cancer Res; 1984 Apr; 44(4):1489-98. PubMed ID: 6608407
[TBL] [Abstract][Full Text] [Related]
4. Immunofluorescent analysis of expression of the RNA tumor virus major glycoprotein, gp71, on the surfaces of normal murine cells.
Cloyd MW; Bolognesi DP; Bigner DD
Cancer Res; 1977 Mar; 37(3):931-8. PubMed ID: 65220
[TBL] [Abstract][Full Text] [Related]
5. Immunofluorescent analysis of expression of the RNA tumor virus major glycoprotein, gp71, on surfaces of virus-producing murine and other mammalian species cell lines.
Cloyd MW; Bolognesi DP; Bigner DD
Cancer Res; 1977 Mar; 37(3):922-30. PubMed ID: 65219
[TBL] [Abstract][Full Text] [Related]
6. Relationships between membrane antigens of human leukemic cells and oncogenic RNA virus structural components.
Metzgar RS; Mohanakumar T; Bolognesi DP
J Exp Med; 1976 Jan; 143(1):47-63. PubMed ID: 53269
[TBL] [Abstract][Full Text] [Related]
7. Effects of in vivo Friend leukemia virus infection on levels of serum thymic factors and on selected T-cell functions in mice.
Tonietti G; Rossi GB; Del Gobbo V; Accinni L; Ranucci A; Titti F; Premrov MG; Garaci E
Cancer Res; 1983 Sep; 43(9):4355-63. PubMed ID: 6347370
[TBL] [Abstract][Full Text] [Related]
8. Resistance against Friend leukemia virus-induced leukemogenesis in DNA-dependent protein kinase (DNA-PK)-deficient scid mice associated with defective viral integration at the Spi-1 and Fli-1 site.
Hasegawa M; Yamaguchi S; Aizawa S; Ikeda H; Tatsumi K; Noda Y; Hirokawa K; Kitagawa M
Leuk Res; 2005 Aug; 29(8):933-42. PubMed ID: 15978944
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Friend leukemia cell visceral metastases by a new monoclonal antibody and role of the immune system of the host in its action.
Sala A; Gresser I; Chassoux D; Maury C; Santodonato L; Eid P; Maunoury MT; Barca S; Cianfriglia M; Belardelli F
Cancer Res; 1992 May; 52(10):2880-9. PubMed ID: 1581903
[TBL] [Abstract][Full Text] [Related]
10. Use of monoclonal anti-gp70 antibodies to mimic the effects of the Rfv-3 gene in mice with Friend virus-induced leukemia.
Britt WJ; Chesebro B
J Immunol; 1983 May; 130(5):2363-7. PubMed ID: 6833759
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy of murine leukemia. XI. differential susceptibility of spleen cells from serum-protected mice to the in vitro immunosuppressive effects of Friend leukemia virus-infected splenocytes.
Pettey CL; Collins JJ
Int J Cancer; 1984 Aug; 34(2):269-76. PubMed ID: 6540757
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy of murine leukemia. IX. The requirement for the Fc portion of antibody for successful passive serum therapy of Friend leukemia virus-induced disease.
Collins JJ; Sackie DM; Johnson GR
Virology; 1983 Apr; 126(1):259-66. PubMed ID: 6573816
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of normal mouse lymphocyte mitogen responses by xenogeneic or allogeneic antibodies to the MuLV glycoprotein gp71.
Lee JC; Ihle JN
J Immunol; 1976 Sep; 117(3):1033-8. PubMed ID: 182879
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy of murine leukemia. V. Protection against Friend leukemia virus-induced immune complex glomerulonephritis by passive serum therapy.
Sanfilippo F; Genovesi EV; Collins JJ
J Natl Cancer Inst; 1981 Sep; 67(3):703-17. PubMed ID: 6456369
[TBL] [Abstract][Full Text] [Related]
15. Detection of the major glycoproteins of Friend leukemia virus (gp71) and the murine mammary tumor virus (gp52) on the surface of mouse cells.
Holder WD; Peer GW; Bolognesi DP; Wells SA
Cancer Res; 1976 Sep; 36(9 pt.1):3217-24. PubMed ID: 184944
[TBL] [Abstract][Full Text] [Related]
16. Immunoglobulins in human serum reactive with murine Friend leukaemia virus.
Bendinelli M; Toniolo A; Matteucci D; Celeste F; Revoltella R
J Gen Virol; 1980 Feb; 46(2):311-24. PubMed ID: 6155429
[TBL] [Abstract][Full Text] [Related]
17. Mitogenic effect of anti-Friend leukemia virus antiserum on T cells.
Senn HP; Papoian R
Eur J Immunol; 1983 Oct; 13(10):824-30. PubMed ID: 6605858
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms in T cell leukemogenesis. II. T cell responses of preleukemic BALB/c mice to Moloney leukemia virus antigens.
Lee JC; Horak I; Ihle JN
J Immunol; 1981 Feb; 126(2):715-22. PubMed ID: 6969759
[TBL] [Abstract][Full Text] [Related]
19. A follow-up study of the development of Rauscher erythroleukemia.
Szabó G; Mátyus L
Cytometry; 1984 Jan; 5(1):92-5. PubMed ID: 6583053
[TBL] [Abstract][Full Text] [Related]
20. Synthetic vaccines against Friend murine leukaemia virus-induced erythroleukaemia: in vivo and in vitro studies with synthetic oligopeptides and sequence-specific antisera.
Bayer H; Hunsmann G
J Gen Virol; 1987 Feb; 68 ( Pt 2)():515-22. PubMed ID: 3469323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
